Two months after cancer surgery, Baker's Gonsioroski ready for football
Knowing the gravity and complexity of Luke’s surgery, Dr. Alexander Kraev of the Billings Clinic made a recommendation to the family to have Dr. Frank Detterback, the Chief of Thoracic Surgery at Yale University and Associated Director of the Yale Cancer Center in New Haven, Conn., do the procedure. “The Lord gave us the best guy in the world,” said Katina. “Kraev was his understudy. He recommended us to his mentor.” Luke and his family left for Yale on June 8.Source: Billings Gazzette
Meriano's Cannoli Truck: A Family's Sweet Mission
Heartened by the care their patriarch received from Yale-New Haven's Smilow Cancer Center, and specifically thoracic surgeon Dr. Daniel Boffa, the Merianos vowed to donate a percentage of sales from the truck to the hospital's Thoracic Oncology Program Fund.Source: CTNow.com
Concurrent Chemoradiation Treatment at High-Volume Facilities Improves Survival for Non-Small Cell Lung Cancer Patients
Patients treated with definitive concurrent chemotherapy and radiation therapy (CCRT) for stage III non-small cell lung cancer (NSCLC) have longer overall survival when treated by highly experienced facilities, whether or not they are academic or community cancer centers.Source: IASLC
For some lung cancer patients, surgery may yield better long-term results
Patients with early stage non-small cell lung cancer (NSCLC) who are otherwise healthy fare better over time if they undergo conventional surgery versus less-invasive radiosurgery to remove their cancer, according to a Yale study. The findings are scheduled to be presented at the 56th annual conference of the American Society for Radiation Oncology in San Francisco.
The benefits of annual low-dose CT lung cancer screening, done in a structured program similar to the National Lung Screening Trial, clearly outweigh the risks of radiation exposure.
A multi-society, comprehensive, systematic review concluded that screening 10,000 individuals at elevated risk for lung cancer with annual low-dose CT will prevent approximately 30 lung cancer deaths but cause approximately three radiation-induced cancers, typically 10 to 20 years later.
Yale Study Finds Reassuring Outcome Trends for Heart Valve Replacement Therapies
A new, Yale-led study, published Nov. 22 in the Journal of the American College of Cardiology, answers fundamental questions about the characteristics and outcomes of traditional and less-invasive treatment options for older adults who require aortic valve replacement.
Dr. Nassiri is selected to the International Society for Study of Vascular Anomalies (ISSVA) task force on classification of vascular anomalies
Dr. Nassiri is selected to represent the United States and the Specialty of Vascular Surgery on the International Society for Study of Vascular Anomalies (ISSVA) Ad-hoc Committee for Classification of Vascular Anomalies.Source: ISSVA Newsletter Vol 5 - No 1 | April 2021
The Yale Larynx Lab chosen as cover of Oncotarget, Vol 11, Issue 35
The cover for issue 35 of Oncotarget features Figure 4, "The in vivo pre- or post- topical application of BAY 11-7082 prevents the acidic bile-induced deregulation of cancer-related miRNA markers in 10-day exposed murine HM," by Vageli, et. al.